VEGFA and neoplasm: Maintenance of pericytes and their associated vascular basal membranes, along with the elevated secretion of proangiogenic factors, leads to rapid and physiologically relevant regrowth of tumor vessels after cessation of anti-VEGF-A therapy, thereby contributing to therapeutic failure [43,44,45,46,47].